Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnold Pinter

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Journal of Cardiovascular Pharmacology and Therapeutics|January 29, 2005
The burden of atrial fibrillation: should we abandon antiarrhythmic drug therapy?Paul Dorian, Iqwal Mangat, Arnold Pinter, et al.
The Canadian Journal of Cardiology|December 20, 2011
Complications of variant angina: a case reportAdam Bohm, Robert Kiss, Paul Dorian, et al.
The Canadian Journal of Cardiology|November 16, 2010
Single-chamber, rate-responsive pacemaker-mediated tachycardiaAdam Bohm, Robert Kiss, Paul Dorian, et al.
Journal of the American Heart Association|January 22, 2019
Unexpected High Prevalence of Cardiovascular Disease Risk Factors and Psychiatric Disease Among Young People With Sudden Cardiac ArrestKatherine S Allan, Laurie J Morrison, Arnold Pinter, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 23, 2010
Role of antiarrhythmic drugs in patients with implantable cardioverter defibrillatorsHugo Van Herendael, Arnold Pinter, Kamran Ahmad, et al.
Resuscitation|June 13, 2017
"Presumed cardiac" arrest in children and young adults: A misnomer?Katherine S Allan, Laurie J Morrison, Arnold Pinter, et al.
Journal of Cardiovascular Pharmacology|August 2, 2007
The effect of vernakalant (RSD1235), an investigational antiarrhythmic agent, on atrial electrophysiology in humansPaul Dorian, Arnold Pinter, Iqwal Mangat, et al.
The Canadian Journal of Cardiology|October 9, 2009
Outcomes in heart failure patients referred for consideration of implantable cardioverter defibrillator for primary prophylaxis of sudden cardiac death: what are the risks of waiting?Nina Ghosh, Iqwal Mangat, Suzan S O'Donnell, et al.
Journal of the American Heart Association|August 19, 2020
Microvolt QRS Alternans Without Microvolt T-Wave Alternans in Human Cardiomyopathy: A Novel Risk Marker of Late Ventricular ArrhythmiasAdrian Suszko, Sachin Nayyar, Christopher Labos, et al.
The Canadian Journal of Cardiology|March 31, 2010
Limitations in the current screening practice of assessing left ventricular ejection fraction for a primary prophylactic implantable defibrillator in southern OntarioChristopher Lane, Paul Dorian, Nina Ghosh, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Journal of Cardiovascular Pharmacology and Therapeutics|January 29, 2005
The burden of atrial fibrillation: should we abandon antiarrhythmic drug therapy?Paul Dorian, Iqwal Mangat, Arnold Pinter, et al.
The Canadian Journal of Cardiology|December 20, 2011
Complications of variant angina: a case reportAdam Bohm, Robert Kiss, Paul Dorian, et al.
The Canadian Journal of Cardiology|November 16, 2010
Single-chamber, rate-responsive pacemaker-mediated tachycardiaAdam Bohm, Robert Kiss, Paul Dorian, et al.
Journal of the American Heart Association|January 22, 2019
Unexpected High Prevalence of Cardiovascular Disease Risk Factors and Psychiatric Disease Among Young People With Sudden Cardiac ArrestKatherine S Allan, Laurie J Morrison, Arnold Pinter, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 23, 2010
Role of antiarrhythmic drugs in patients with implantable cardioverter defibrillatorsHugo Van Herendael, Arnold Pinter, Kamran Ahmad, et al.
Resuscitation|June 13, 2017
"Presumed cardiac" arrest in children and young adults: A misnomer?Katherine S Allan, Laurie J Morrison, Arnold Pinter, et al.
Journal of Cardiovascular Pharmacology|August 2, 2007
The effect of vernakalant (RSD1235), an investigational antiarrhythmic agent, on atrial electrophysiology in humansPaul Dorian, Arnold Pinter, Iqwal Mangat, et al.
The Canadian Journal of Cardiology|October 9, 2009
Outcomes in heart failure patients referred for consideration of implantable cardioverter defibrillator for primary prophylaxis of sudden cardiac death: what are the risks of waiting?Nina Ghosh, Iqwal Mangat, Suzan S O'Donnell, et al.
Journal of the American Heart Association|August 19, 2020
Microvolt QRS Alternans Without Microvolt T-Wave Alternans in Human Cardiomyopathy: A Novel Risk Marker of Late Ventricular ArrhythmiasAdrian Suszko, Sachin Nayyar, Christopher Labos, et al.
The Canadian Journal of Cardiology|March 31, 2010
Limitations in the current screening practice of assessing left ventricular ejection fraction for a primary prophylactic implantable defibrillator in southern OntarioChristopher Lane, Paul Dorian, Nina Ghosh, et al.
Pageof 4